Radiologists encouraged to look beyond cancer for clinically unseen diseases

August 14, 2007

Radiologists can diagnose venous thromboembolic disease (VTED) in cancer patients earlier by looking more carefully at CT scans of the thorax, abdomen, and pelvis which are regularly done to determine the extent or stage of the cancer, according to a recent study conducted by radiologists at the University College Hospital in Galway, Ireland.

Venous thromboembolic disease can be fatal if left untreated. The study focused on pulmonary embolism (PE), inferior vena cava (IVC), and iliac and iliofemoral deep venous thromboses (DVTs) in oncology patients.

“We’d noticed a number of clinically unsuspected deep venous thrombosis and pulmonary emboli on staging CT thorax, abdomen and pelvis examinations which goes unnoticed,” said Carmel Cronin, MD, lead author of the study. “When we do a CT to stage the cancer we can see both the pulmonary arterial system and the pelvic and lower extremity venous system,” she said.

The study included 736 patients ranging from 20 to 79 years of age. According to the study, 23 patients had unsuspected iliofemoral DVT and four had common iliac vein involvement. The study also showed that 13 patients had an unsuspected pulmonary embolism.

“We were surprised by the results, said Dr. Cronin. “However, as outlined in other literature, the true prevalence of venous thromboembolic disease is underestimated as many are clinically unapparent. Venous thrombosis is estimated to be diagnosed in less than 40% of those with a concomitant venous thrombosis and malignancy,” she said.

Source: American Roentgen Ray Society

Explore further: Deep vein thrombosis recommendations

Related Stories

Deep vein thrombosis recommendations

September 20, 2017
The first comprehensive European advice on deep vein thrombosis was recentely published in the European Heart Journal. The recommendations were produced by the European Society of Cardiology (ESC) Working Group on Aorta and ...

Extended thromboprophylaxis safe, effective after liver surgery

September 19, 2017
(HealthDay)—For patients undergoing liver surgery, extended pharmacologic thromboprophylaxis appears effective and safe, according to a study published online Aug. 28 in the Journal of Thrombosis and Haemostasis.

ESC focused update on dual antiplatelet therapy in coronary artery disease published today

August 26, 2017
The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal, and on the ESC website. The document was developed in collaboration with the European ...

FDA approves first biosimilar drug for cancer

September 15, 2017
(HealthDay)—The first biosimilar drug to treat cancer has been approved by the U.S. Food and Drug Administration.

Hokusai-VTE study suggests certain sub-groups of venous thromboembolism patients may need review

September 1, 2013
In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin ...

Unsuspected PE seldom linked to death in cancer patients

October 9, 2012
(HealthDay)—Unsuspected pulmonary embolism (UPE) is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism (PE), according to research published in the October ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.